Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
The Bone & Joint Journal
|
January 28, 2021
Coronavirus infection in hip fractures (CHIP) study
Aatif Mahmood, Fatima Rashid, Richard Limb, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2017
Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement
Matthew J Ferris, Hasan Danish, Jeffrey M Switchenko, et al.
Pediatric Blood & Cancer
|
June 15, 2016
Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group
Thomas Cash, Elizabeth McIlvaine, Mark D Krailo, et al.
Pediatric Blood & Cancer
|
August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project
Mallory R Taylor, James R Anderson, Julie R Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031
Thomas Cash, Mark D Krailo, Allen B Buxton, et al.
Pediatric Blood & Cancer
|
March 13, 2026
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study
Benjamin J Lerman, Madeleine King, Rajen Mody, et al.
Immunity
|
October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
JCO Precision Oncology
|
May 11, 2022
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care
Ryan J Summers, Sharon M Castellino, Christopher C Porter, et al.
Pediatric Blood & Cancer
|
November 6, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE
Gemma Bryan, Louise Guolla, Gabriela Inés Villanueva, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
The Bone & Joint Journal
|
January 28, 2021
Coronavirus infection in hip fractures (CHIP) study
Aatif Mahmood, Fatima Rashid, Richard Limb, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 1, 2017
Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement
Matthew J Ferris, Hasan Danish, Jeffrey M Switchenko, et al.
Pediatric Blood & Cancer
|
June 15, 2016
Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group
Thomas Cash, Elizabeth McIlvaine, Mark D Krailo, et al.
Pediatric Blood & Cancer
|
August 29, 2025
Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From the International Neuroblastoma Risk Group (INRG) Project
Mallory R Taylor, James R Anderson, Julie R Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Birgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 31, 2023
Long-Term Outcomes in Patients With Localized Ewing Sarcoma Treated With Interval-Compressed Chemotherapy on Children's Oncology Group Study AEWS0031
Thomas Cash, Mark D Krailo, Allen B Buxton, et al.
Pediatric Blood & Cancer
|
March 13, 2026
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study
Benjamin J Lerman, Madeleine King, Rajen Mody, et al.
Immunity
|
October 6, 2021
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity
Madhav D Sharma, Rafal Pacholczyk, Huidong Shi, et al.
JCO Precision Oncology
|
May 11, 2022
Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care
Ryan J Summers, Sharon M Castellino, Christopher C Porter, et al.
Pediatric Blood & Cancer
|
November 6, 2024
Impact of the COVID-19 Pandemic Onset on the Early Careers of Pediatric Oncology Health Professionals and Researchers: A Report From the Children's Oncology Group Young Investigators Committee, Young SIOP Network, and Young SIOPE
Gemma Bryan, Louise Guolla, Gabriela Inés Villanueva, et al.
Page
of 5